| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536501 | Vaccine | 2017 | 9 Pages |
Abstract
There was a paucity of cost-effectiveness models evaluating vaccination targeted to the Hong Kong population. All evaluated vaccinations and immunisation interventions in Hong Kong, except for Haemophilus influenzae b, hepatitis A and HPV vaccinations, were considered either cost-saving or very cost-effective when compared to status quo.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Carlos K.H. Wong, Qiuyan Liao, Vivian Y.W. Guo, Yiqiao Xin, Cindy L.K. Lam,